Cargando…
Gut Microbiota and Related Electronic Multisensorial System Changes in Subjects With Symptomatic Uncomplicated Diverticular Disease Undergoing Rifaximin Therapy
Background: Intestinal dysbiosis might play a pathogenetic role in subjects with symptomatic uncomplicated diverticular disease (SUDD), but the effect of rifaximin therapy has been scantly explored with regard to gut microbiota variations in patients with SUDD. Aims: To verify to which extent rifaxi...
Autores principales: | De Vincentis, Antonio, Santonico, Marco, Del Chierico, Federica, Altomare, Annamaria, Marigliano, Benedetta, Laudisio, Alice, Reddel, Sofia, Grasso, Simone, Zompanti, Alessandro, Pennazza, Giorgio, Putignani, Lorenza, Guarino, Michele Pier Luca, Cicala, Michele, Antonelli Incalzi, Raffaele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326398/ https://www.ncbi.nlm.nih.gov/pubmed/34350192 http://dx.doi.org/10.3389/fmed.2021.655474 |
Ejemplares similares
-
Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease
por: Altomare, Annamaria, et al.
Publicado: (2021) -
Diagnosis of symptomatic uncomplicated diverticular disease and the role of Rifaximin in management
por: Maconi, Giovanni
Publicado: (2017) -
Uncomplicated Diverticular Disease: Innate and Adaptive Immunity in Human Gut Mucosa before and after Rifaximin
por: Cianci, Rossella, et al.
Publicado: (2014) -
Diverticular Disease and Rifaximin: An Evidence-Based Review
por: Piccin, Anna, et al.
Publicado: (2023) -
Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients
por: Lo Presti, Alessandra, et al.
Publicado: (2023)